Ken Griffin Integra Lifesciences Holdings Corp Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$17.14 - $31.74 $238,246 - $441,186	13,900 Added 1985.71%	14,600 $265,000
Q2 2024 Aug 14, 2024	SELL	$23.14 - $34.72 $30,082 - $45,136	-1,300 Reduced 65.0%	700 $20,000
Q1 2024 May 15, 2024	SELL	$33.4 - $45.2 $40,080 - $54,240	-1,200 Reduced 37.5%	2,000 $70,000
Q4 2023 Feb 14, 2024	BUY	$34.21 - $44.59 $109,472 - $142,688	3,200 New	3,200 $139,000
Q2 2023 Aug 14, 2023	SELL	$37.95 - $58.98 $94,875 - $147,450	-2,500 Reduced 36.76%	4,300 $176,000
Q1 2023 May 15, 2023	BUY	$52.61 - $60.49 $126,264 - $145,176	2,400 Added 54.55%	6,800 $390,000
Q4 2022 Feb 14, 2023	BUY	$42.17 - $58.6 $185,548 - $257,840	4,400 New	4,400 $246,000

241

75.3M

585K

21.3K

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.85B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.